Pfizer Inc
NYSE: PFE
$26.02
-$0.70 (-2.6%)
Closing Price on November 14, 2024
PFE Articles
Glencore’s IPO will be for about $11 billion. (Reuters) The slide of the dollar has caused concerns about how it may hurt the stability of the credit markets. (Reuters) Portugal set a bailout with...
Published:
Twitter has, by most estimates, 175 million members, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some have more than one million...
Published:
The death of Osama bin Laden raised US futures and the dollar and pushed crude oil lower. (Reuters) The US helped cut the amount of oil China imported from Iran to punish the ruling government in the...
Published:
Next week will mark the third week of the full daily earnings onslaught in what is really the fourth week of earnings season. There are many market-moving companies and sector-moving companies...
Published:
Last Updated:
The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom in the industry. The good news is that the drug sector does still offer...
Published:
Last Updated:
The Fed’s exit from QE2 may involve rate increases (Reuters) Deutsche Bank will restructure its US bank business to avoid regulation (WSJ) Google’s (NASDAQ: GOOG) new CEO will be carefully...
Published:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Baker Hughes Inc. (NYSE: BHI) Raised to Outperform at Credit Suisse....
Published:
Last Updated:
Republicans plan to cut $6 trillion from the budget over the next decade (Reuters) Google (NASDAQ: GOOG) may be investigated by the FTC (Bloomberg) The FAA will begin inspection of most older Boeing...
Published:
Last Updated:
David Sokol’s trading in Lubrizol before Berkshire Hathaway (NYSE: BRK) bought it may cause regulators to review the transaction. (Reuters) The Inspector General of the Federal Housing Finance...
Published:
America lost its lead as the world’s top manufacturer to China. That is in part the basis of the argument that China’s Gross Domestic Product will pass America’s sometime before the middle of...
Published:
Last Updated:
It is time for “The Daily Dividend” and we have an interesting call ahead. How long has it been that Amgen Inc. (NASDAQ: AMGN) has been touted as a “Should Be” dividend stock? Too...
Published:
Last Updated:
It’s the BioHeath Daily for key developments in drugs, biotech, and medical developments. Prana Biotechnology Ltd. (NASDAQ: PRAN) is often overlooked here in the U.S. as it has such a small...
Published:
Last Updated:
Many shareholders argue that share repurchase and stock buyback plans are generally a waste of shareholder capital aimed solely as a short-term share price targeting mechanism. Many would prefer to...
Published:
Last Updated:
The method of using capital from the corporate treasury to return capital to shareholders via share repurchase programs has long been under question. Most buybacks never are fully utilized, and...
Published:
Last Updated:
Economists cheered the ADP data that showed the private sector added 187,000 jobs in January. It did not help the stock market much but was probably offset by bad news from Egypt. The ADP figures may...
Published: